Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
30
2026

How 2026 Code Changes Shifted SRT from Sensus Healthcare to a Standard Treatment Option

For nearly a century, surgical excision and Mohs surgery have been the gold standard for treating patients who have non-melanoma skin cancer (NMSC) and keloid disease. The surgery works extremely well – with cure rates…

March
10
2016

The SRT-100™ is Revolutionizing Keloid Scar Treatment for Your Patients

Allow us to paint a scenario for you; a patient comes into your practice and seeks keloid treatment after removal. Imagine a process to reduce the chance of a recurrence of his or her scars…

January
19
2016

Give Your Patients Peace of Mind with the SRT-100™ for Basal Cell Carcinoma Treatment

Patients who are diagnosed with basal cell carcinomas have a number of treatment options available. As a physician, you are well aware that most of those options involve surgery of some sort — an unsettling…

January
19
2016

SRT-100™: The Non-Surgical Basal Cell Carcinoma Treatment for Patients Facing Skin Cancer

Basal cell carcinoma is the most frequently occurring form of skin cancer, with more than 2.5 million new cases diagnosed in the U.S. each year. More than one in every three new cancers is skin…

December
07
2015

Offer Your Patients the Best Skin Cancer Treatment Options with SRT-100™

As a physician, it is up to you to make sure your patients have access to and are making the best choices possible when it comes to treating their skin cancer. To do so, you…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry